414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer

E. Fontana; Gerald Steven Falchook; Loic Verlingue; Louise Carter; T. De La Motte Rouge; Chiara Baldini; V. Boni; Angel Montero; B. Doger de Spéville; Jordi Rodon Ahnert; C. Vicier; R. Balaraman; M. Mckean; L Demars; G. Brown; C. Xu; J.  Bader; A Italiano; A. de Rienzo

doi:10.1016/j.esmoop.2025.104985

414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer

E. Fontana, Gerald Steven Falchook, Loic Verlingue, Louise Carter, T. De La Motte Rouge, Chiara Baldini, V. Boni, Angel Montero, B. Doger de Spéville, Jordi Rodon Ahnert, C. Vicier, R. Balaraman, M. Mckean, L Demars, G. Brown, C. Xu, J. Bader, A Italiano, A. de Rienzo

Division of Cancer Sciences (L5)

Research output: Chapter in Book/Conference proceeding › Conference contribution › peer-review

Original language	English
Title of host publication	Abstract Book of the ESMO Breast Cancer Congress 2025Munich, Germany 14-17 May 2025
Publisher	ESMO Press
Pages	104985
Volume	10
DOIs	https://doi.org/10.1016/j.esmoop.2025.104985
Publication status	Published - 1 May 2025

Publication series

Name	ESMO Open
Publisher	ESMO Press
ISSN (Print)	2059-7029

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.esmoop.2025.104985Licence: CC BY-NC-ND

Cite this

Fontana, E., Falchook, G. S., Verlingue, L., Carter, L., De La Motte Rouge, T., Baldini, C., Boni, V., Montero, A., Doger de Spéville, B., Rodon Ahnert, J., Vicier, C., Balaraman, R., Mckean, M., Demars, L., Brown, G., Xu, C., Bader, J., Italiano, A., & Rienzo, A. D. (2025). 414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer. In Abstract Book of the ESMO Breast Cancer Congress 2025Munich, Germany 14-17 May 2025 (Vol. 10, pp. 104985). (ESMO Open). ESMO Press. https://doi.org/10.1016/j.esmoop.2025.104985

@inproceedings{70fe60102d0e472db88cab154bcbc174,

title = "414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer",

author = "E. Fontana and Falchook, \{Gerald Steven\} and Loic Verlingue and Louise Carter and \{De La Motte Rouge\}, T. and Chiara Baldini and V. Boni and Angel Montero and \{Doger de Sp{\'e}ville\}, B. and \{Rodon Ahnert\}, Jordi and C. Vicier and R. Balaraman and M. Mckean and L Demars and G. Brown and C. Xu and J. Bader and A Italiano and Rienzo, \{A. de\}",

year = "2025",

month = may,

day = "1",

doi = "10.1016/j.esmoop.2025.104985",

language = "English",

volume = "10",

series = "ESMO Open",

publisher = "ESMO Press",

pages = "104985",

booktitle = "Abstract Book of the ESMO Breast Cancer Congress 2025Munich, Germany 14-17 May 2025",

address = "Switzerland",

}

Fontana, E, Falchook, GS, Verlingue, L, Carter, L, De La Motte Rouge, T, Baldini, C, Boni, V, Montero, A, Doger de Spéville, B, Rodon Ahnert, J, Vicier, C, Balaraman, R, Mckean, M, Demars, L, Brown, G, Xu, C, Bader, J, Italiano, A & Rienzo, AD 2025, 414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer. in Abstract Book of the ESMO Breast Cancer Congress 2025Munich, Germany 14-17 May 2025. vol. 10, ESMO Open, ESMO Press, pp. 104985. https://doi.org/10.1016/j.esmoop.2025.104985

414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer. / Fontana, E.; Falchook, Gerald Steven; Verlingue, Loic et al.
Abstract Book of the ESMO Breast Cancer Congress 2025Munich, Germany 14-17 May 2025. Vol. 10 ESMO Press, 2025. p. 104985 (ESMO Open).

Research output: Chapter in Book/Conference proceeding › Conference contribution › peer-review

TY - GEN

T1 - 414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer

AU - Fontana, E.

AU - Falchook, Gerald Steven

AU - Verlingue, Loic

AU - Carter, Louise

AU - De La Motte Rouge, T.

AU - Baldini, Chiara

AU - Boni, V.

AU - Montero, Angel

AU - Doger de Spéville, B.

AU - Rodon Ahnert, Jordi

AU - Vicier, C.

AU - Balaraman, R.

AU - Mckean, M.

AU - Demars, L

AU - Brown, G.

AU - Xu, C.

AU - Bader, J.

AU - Italiano, A

AU - Rienzo, A. de

PY - 2025/5/1

Y1 - 2025/5/1

U2 - 10.1016/j.esmoop.2025.104985

DO - 10.1016/j.esmoop.2025.104985

M3 - Conference contribution

VL - 10

T3 - ESMO Open

SP - 104985

BT - Abstract Book of the ESMO Breast Cancer Congress 2025Munich, Germany 14-17 May 2025

PB - ESMO Press

ER -

Fontana E, Falchook GS, Verlingue L, Carter L, De La Motte Rouge T, Baldini C et al. 414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer. In Abstract Book of the ESMO Breast Cancer Congress 2025Munich, Germany 14-17 May 2025. Vol. 10. ESMO Press. 2025. p. 104985. (ESMO Open). doi: 10.1016/j.esmoop.2025.104985